Finance

Beta
Lists
TOVX:NYSEAMERICAN
Theriva Biologics Inc
$0.26
-9.66%
(-0.027) 1D
$0.25
-0.90% (-0.0023)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TOVX...
Open
$0.28
High
$0.28
Low
$0.24
Mkt. cap
11.82M
Avg. vol.
2.86M
Volume
2.48M
52-wk high
$0.86
52-wk low
$0.16
EPS
-$2.55
Beta
1.10
Shares outstanding
45.89M
No. of employees
15
Open
$0.28
High
$0.28
Low
$0.24
Mkt. cap
11.82M
Avg. vol.
2.86M
Volume
2.48M
52-wk high
$0.86
52-wk low
$0.16
EPS
-$2.55
Beta
1.10
Shares outstanding
45.89M
No. of employees
15
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to TOVX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for TOVX in the last 3 months.
Highest
Current $0.26
$4.00 (+1,467.40%)
Average
$2.50 (+879.62%)
Lowest
$1.00 (+291.85%)
News stories
From sources across the web
About Theriva Biologics Inc
CEO-
Employees15
Founded1986
HeadquartersRockville, Maryland, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
300.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.95M
2.55M
1.13M
355.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.18M
1.26M
1.71M
2.07M
Operating expense
13.13M
3.81M
2.84M
2.43M
Total operating expenses
13.13M
3.81M
2.84M
2.43M
Operating income
-13.13M
-3.81M
-2.84M
-2.13M
Other non operating income
-
-
-
-
EBT including unusual items
-13.06M
-4.36M
-2.00M
-2.04M
EBT excluding unusual items
-13.06M
-3.73M
-2.77M
-2.04M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13.06M
-4.36M
-2.00M
-2.04M
Net profit margin
-
-
-
-681.33%
Earnings per share
-1.93
-0.45
-
-0.05
Interest and investment income
54.00K
65.00K
72.00K
82.00K
Interest expense
-
-
-
-
Net interest expenses
54.00K
65.00K
72.00K
82.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.10M
-3.78M
-2.81M
-2.10M
Gain or loss from assets sale
-
-
1.00K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more